|
|
Article: SkyePharma Announces FORADIL CERTIHALER Approved in Germany.
- Article from:
- PR Newswire
- Article date:
- June 20, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, June 20 /PRNewswire-FirstCall/ -- SkyePharma PLC ( LSE: SKP) announces today that the German pharmaceutical regulatory authority has approved FORADIL(R) CERTIHALER(TM) (formoterol fumarate inhalation powder) for the treatment of asthma and chronic obstructive pulmonary disease ("COPD"). FORADIL(R) CERTIHALER(TM) was co-developed by SkyePharma PLC and Novartis Pharma AG. FORADIL(R) CERTIHALER(TM) is a trademark of Novartis. FORADIL(R) CERTIHALER(TM) was submitted for regulatory review in Europe on a country-by-country basis beginning in December 2002 and has now been approved in Switzerland, Austria, Finland, Portugal and the Netherlands as well as in Germany. It ...